Venous Thromboembolic Disease: Clinical Trials

1 trial for Venous Thromboembolic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Venous Thromboembolic Disease: new trials by email Literature Review of Venous Thromboembolic Disease trials Research Report on Venous Thromboembolic Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
ATI-5923, Coumadin (warfarin) - Atrial Fibrillation, Atrial Flutter
Phase 2 / Phase 3UnknownARYx Therapeutics6002008-05-012010-02-02

Narrower conditions

Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Cardiomyopathies (1)  ·  Myocardial Infarction (1)

Broader conditions

Arrhythmias, Cardiac (1)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Warfarin (1)  ·  tecarfarin (1)

Sponsors

ARYx Therapeutics (1)

Countries

United States (1)